Process of Preparation of Erlotinib
This technology is related to process of preparing of Erlotinib. What is the Novelty? The earlier technologies for preparing [6,7-bis-(2methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride (Erlotinib) having low yield about 50% -75% whereas present technology gives high yield, in addition has significant advantage in terms of time and cost. This technology can produce Erlotinib in less synthetic steps.
Sector: Pharmaceuticals
Country: India
Area of Application: Medical indsutry.
Keywords: Erlotinib,tyrosine kinase.
Advantages: Non-Infringing method of producing Erlotinib. Cost Effective drug. High yield compared to earlier Erlotinib production. methods Huge market opportunity. FDA approval for Erlotinib.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054